People: POZEN Inc (POZN.O)
6 Dec 2013
Dr. Seth A. Rudnick, M.D., is Independent Director of Pozen Inc., since July 25, 2011. He is Venture partner and previously general partner at Canaan Partners, a venture capital firm, since 1998. Formerly, Chief Executive Officer and Chairman of CytoTherapeutics Inc., a company developing stem cell-based therapies. Helped found and served as the Head of Research and Development for Ortho Biotech, a division of Johnson & Johnson focusing on cancer and chronic illnesses from 1991 to 1998. Serves of the Boards of the following privately held biotechnology companies: Chimerix, Inc., Liquidia Technologies, Inc., ORTHOCON, Inc., Spine Wave, Inc. and VaxInnate, Inc. Currently a Clinical Adjunct Professor of Medicine at University of North Carolina, Chapel Hill.
|Total Annual Compensation,||Long-Term Incentive Plans,||All Other,||Fiscal Year Total,|